Methyl ergoline-8b-carboxylate hydrochloride is a synthetic ergoline derivative. Ergoline alkaloids are a class of compounds known for their complex tetracyclic structure, which serves as the core scaffold for numerous biologically active molecules. This specific compound, as a hydrochloride salt, is typically a solid with improved stability and handling properties compared to its free base form. This compound is primarily utilized as a key pharmaceutical intermediate in the research and development of central nervous system (CNS) drugs. The ergoline scaffold is historically significant and is found in medications targeting serotonin and dopamine receptors. Therefore, Methyl ergoline-8b-carboxylate HCl is a crucial building block for synthesizing potential therapeutic agents for neurological and psychiatric disorders, including migraines (e.g., ergotamine derivatives) and Parkinson's disease. Its use is almost exclusively confined to advanced organic synthesis within medicinal chemistry and pharmaceutical manufacturing. Handling requires appropriate safety precautions due to the potent biological activity associated with ergoline alkaloids.